{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:41:19Z","timestamp":1781736079877,"version":"3.54.5"},"reference-count":213,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007235","name":"Colorado State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007235","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>With an intrinsically low ability for self-repair, articular cartilage injuries often progress to cartilage loss and joint degeneration resulting in osteoarthritis (OA). Osteoarthritis and the associated articular cartilage changes can be debilitating, resulting in lameness and functional disability both in human and equine patients. While articular cartilage damage plays a central role in the pathogenesis of OA, the contribution of other joint tissues to the pathogenesis of OA has increasingly been recognized thus prompting a whole organ approach for therapeutic strategies. Gene therapy methods have generated significant interest in OA therapy in recent years. These utilize viral or non-viral vectors to deliver therapeutic molecules directly into the joint space with the goal of reprogramming the cells' machinery to secrete high levels of the target protein at the site of injection. Several viral vector-based approaches have demonstrated successful gene transfer with persistent therapeutic levels of transgene expression in the equine joint. As an experimental model, horses represent the pathology of human OA more accurately compared to other animal models. The anatomical and biomechanical similarities between equine and human joints also allow for the use of similar imaging and diagnostic methods as used in humans. In addition, horses experience naturally occurring OA and undergo similar therapies as human patients and, therefore, are a clinically relevant patient population. Thus, further studies utilizing this equine model would not only help advance the field of human OA therapy but also benefit the clinical equine patients with naturally occurring joint disease. In this review, we discuss the advancements in gene therapeutic approaches for the treatment of OA with the horse as a relevant patient population as well as an effective and commonly utilized species as a translational model.<\/jats:p>","DOI":"10.3389\/fvets.2022.962898","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T14:27:49Z","timestamp":1664461669000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Gene therapy approaches for equine osteoarthritis"],"prefix":"10.3389","volume":"9","author":[{"given":"Parvathy","family":"Thampi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Jude","family":"Samulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua C.","family":"Grieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer N.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Wayne","family":"McIlwraith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie R.","family":"Goodrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1002\/art.24984","article-title":"Insurer and out-of-Pocket costs of osteoarthritis in the us: evidence from national survey data","volume":"60","author":"Kotlarz","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/acr.22721","article-title":"Alternative methods for defining osteoarthritis and the impact on estimating prevalence in a us population-based survey","volume":"68","author":"Cisternas","year":"2016","journal-title":"Arthritis Care Res."},{"key":"B3","volume-title":"Diagnosis and Management of Lameness in the Horse","author":"Dyson","year":"2011"},{"key":"B4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tvjl.2004.07.008","article-title":"Medical treatment of osteoarthritis in the horse - a review","volume":"171","author":"Goodrich","year":"2006","journal-title":"Vet J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1302\/2046-3758.111.2000132","article-title":"The horse as a model of naturally occurring osteoarthritis","volume":"1","author":"McIlwraith","year":"2012","journal-title":"Bone Joint Res."},{"key":"B6","volume-title":"Laminitis in US Horses.","author":"USDA","year":"2000"},{"key":"B7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1079\/ECP200428","article-title":"Equine osteoarthritis: a brief review of the disease and its causes","volume":"1","author":"Schlueter","year":"2004","journal-title":"Equine Comp Exerc Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cveq.2007.04.008","article-title":"Evidence-Based lameness detection and quantification","volume":"23","author":"Keegan","year":"2007","journal-title":"Vet Clin N Am Equine Prac."},{"key":"B9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","article-title":"Oarsi guidelines for the non-surgical management of knee osteoarthritis","volume":"22","author":"McAlindon","year":"2014","journal-title":"Osteoarthritis Cartilage."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1007\/s00167-013-2676-8","article-title":"Long-Term results after microfracture treatment for full-thickness knee chondral lesions in athletes","volume":"22","author":"Gobbi","year":"2014","journal-title":"Knee Surg Sports Traumatol Arthrosc."},{"key":"B11","volume-title":"Mosaicplasty for the Treatment of Articular Cartilage Defects: Application in Clinical Practice","author":"Hangody","year":"1998"},{"key":"B12","doi-asserted-by":"publisher","first-page":"S362","DOI":"10.1097\/00003086-200110001-00033","article-title":"Microfracture: surgical technique and rehabilitation to treat chondral defects","volume":"391","author":"Steadman","year":"2001","journal-title":"Clin Orthop Relat Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12178-015-9298-3","article-title":"Osteochondral allograft","volume":"8","author":"Torrie","year":"2015","journal-title":"Curr Rev Musculoskelet Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"602978","DOI":"10.3389\/fvets.2021.602978","article-title":"A comparative review of autologous conditioned serum and autologous protein solution for treatment of osteoarthritis in horses","volume":"8","author":"Camargo Garbin","year":"2021","journal-title":"Front Vet Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"102820","DOI":"10.1016\/j.jevs.2019.102820","article-title":"Platelet-Rich products and their application to osteoarthritis","volume":"86","author":"Garbin","year":"2020","journal-title":"J Equine Vet Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s43465-020-00274-5","article-title":"Efficacy of autologous conditioned serum (Acs), platelet-rich plasma (Prp), hyaluronic acid (Ha) and steroid for early osteoarthritis knee: a comparative analysis","volume":"55","author":"Khurana","year":"2021","journal-title":"Indian J Orthop."},{"key":"B17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.csm.2018.08.001","article-title":"Platelet-Rich plasma","volume":"38","author":"Le","year":"2019","journal-title":"Clin Sports Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1056\/NEJM199410063311401","article-title":"Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation","volume":"331","author":"Brittberg","year":"1994","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1177\/0363546518756976","article-title":"Matrix-Applied characterized autologous cultured chondrocytes versus microfracture: five-year follow-up of a prospective randomized trial","volume":"46","author":"Brittberg","year":"2018","journal-title":"Am J Sports Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.knee.2016.12.002","article-title":"Surgical treatments of cartilage defects of the knee: systematic review of randomised controlled trials","volume":"24","author":"Devitt","year":"2017","journal-title":"Knee."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.arthro.2013.07.271","article-title":"Evidence-Based status of second-and third-generation autologous chondrocyte implantation over first generation: a systematic review of level I and II studies","volume":"29","author":"Goyal","year":"2013","journal-title":"Arthroscopy."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-2555-3-10","article-title":"Maci-a new era?","volume":"3","author":"Jacobi","year":"2011","journal-title":"Sports Med Arthrosc Rehabil Ther Technol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.5124\/jkma.2013.56.12.1123","article-title":"Pharmacologic treatment of osteoarthritis","volume":"56","author":"Baek","year":"2013","journal-title":"J Korean Med Assoc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13018-016-0346-5","article-title":"Animal models of osteoarthritis: classification, update, and measurement of outcomes","volume":"11","author":"Kuyinu","year":"2016","journal-title":"J Orthop Surg Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1208\/s12248-013-9454-x","article-title":"Animal models of osteoarthritis: challenges of model selection and analysis","volume":"15","author":"Teeple","year":"2013","journal-title":"AAPS J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.joca.2008.11.008","article-title":"Preclinical animal models in single site cartilage defect testing: a systematic review","volume":"17","author":"Ahern","year":"2009","journal-title":"Osteoarthritis Cartilage."},{"key":"B27","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0736-0266(00)90015-9","article-title":"Autologous chondrocyte implantation in a canine model: change in composition of reparative tissue with time","volume":"19","author":"Breinan","year":"2001","journal-title":"J Orthop Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1177\/1947603511401905","article-title":"Preclinical studies for cartilage repair: recommendations from the international cartilage repair society","volume":"2","author":"Hurtig","year":"2011","journal-title":"Cartilage."},{"key":"B29","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/0192623316641784","article-title":"The miniature swine as a model in experimental and translational medicine","volume":"44","author":"Stricker-Krongrad","year":"2016","journal-title":"Toxicol Pathol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1055\/s-0038-1632990","article-title":"A comparative study of articular cartilage thickness in the stifle of animal species used in human pre-clinical studies compared to articular cartilage thickness in the human knee","volume":"19","author":"Frisbie","year":"2006","journal-title":"Vet Comp Orthop Traumatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"826","DOI":"10.2106\/00004623-200106000-00003","article-title":"Immunolocalization of matrix metalloproteinases in partial-thickness defects in pig articular cartilage. A preliminary report","volume":"83","author":"Hembry","year":"2001","journal-title":"J Bone Joint Surg Am."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.joca.2012.06.005","article-title":"Comparative study of depth-dependent characteristics of equine and human osteochondral tissue from the medial and lateral femoral condyles","volume":"20","author":"Malda","year":"2012","journal-title":"Osteoarthritis Cartilage."},{"key":"B33","article-title":"From arthroscopy to gene therapy-\u221230 years of looking in joints","volume-title":"Proceedings of the Annual Convention","author":"McIlwraith","year":"2005"},{"key":"B34","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/evj.12689","article-title":"Use of contrast media in computed tomography and magnetic resonance imaging in horses: techniques, adverse events and opportunities","volume":"49","author":"Nelson","year":"2017","journal-title":"Equine Vet J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/evj.12808","article-title":"Recent advances in articular cartilage evaluation using computed tomography and magnetic resonance imaging","volume":"50","author":"Nelson","year":"2018","journal-title":"Equine Vet J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/sj.gt.3301608","article-title":"Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene","volume":"9","author":"Frisbie","year":"2002","journal-title":"Gene Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1002\/jor.20382","article-title":"Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model","volume":"25","author":"Wilke","year":"2007","journal-title":"J Orthop Res."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.3390\/ani11113247","article-title":"Role of innate immunity in initiation and progression of osteoarthritis, with emphasis on horses","volume":"11","author":"Estrada McDermott","year":"2021","journal-title":"Animals."},{"key":"B39","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/B978-1-4377-0867-7.00078-8","article-title":"Synovial joint biology and pathobiology","volume-title":"Equine Surgery","author":"Frisbie","year":"2012"},{"key":"B40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/B978-1-4557-5969-9.00003-6","article-title":"Traumatic arthritis and posttraumatic osteoarthritis in the horse.","volume-title":"Joint Disease in the Horse","author":"McIlwraith","year":"2016"},{"key":"B41","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.joca.2019.12.007","article-title":"the role of macrophages in osteoarthritis and cartilage repair","volume":"28","author":"Wu","year":"2020","journal-title":"Osteoarthritis Cartilage."},{"key":"B42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/jor.24457","article-title":"Role of inflammation and the immune system in the progression of osteoarthritis","volume":"38","author":"Woodell-May","year":"2020","journal-title":"J Orthop Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-Grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat Rev Rheumatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/BOR.0000000000000353","article-title":"Role of low-grade inflammation in osteoarthritis","volume":"29","author":"Scanzello","year":"2017","journal-title":"Curr Opin Rheumatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/1759720X12467868","article-title":"Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations","volume":"5","author":"Sokolove","year":"2013","journal-title":"Ther Adv Musculoskelet Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/cells8070734","article-title":"Nf-Kb signaling pathways in osteoarthritic cartilage destruction","volume":"8","author":"Choi","year":"2019","journal-title":"Cells."},{"key":"B47","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2174\/156652309788488569","article-title":"Gene therapy targeting nuclear factor-kappab: towards clinical application in inflammatory diseases and cancer","volume":"9","author":"Tas","year":"2009","journal-title":"Curr Gene Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.joca.2006.04.008","article-title":"Nf-Kb as a potential therapeutic target in osteoarthritis and rheumatoid arthritis","volume":"14","author":"Roman-Blas","year":"2006","journal-title":"Osteoarthritis Cartilage."},{"key":"B49","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"Nf-Kb signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrrheum.2013.159","article-title":"Progress in intra-articular therapy","volume":"10","author":"Evans","year":"2014","journal-title":"Nat Rev Rheumatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1136\/ard.54.5.424","article-title":"Synovial perfusion and synovial fluid solutes","volume":"54","author":"Simkin","year":"1995","journal-title":"Ann Rheum Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1002\/jps.21346","article-title":"Intra-Articular depot formulation principles: role in the management of postoperative pain and arthritic disorders","volume":"97","author":"Larsen","year":"2008","journal-title":"J Pharm Sci."},{"key":"B53","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.93000","article-title":"Gene therapy for the treatment of equine osteoarthritis","volume-title":"Equine Science","author":"Levings","year":"2020"},{"key":"B54","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1089\/dna.1992.11.227","article-title":"Gene transfer to synoviocytes: prospects for gene treatment of arthritis","volume":"11","author":"Bandara","year":"1992","journal-title":"DNA Cell Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1196\/annals.1402.065","article-title":"Gene therapy in musculoskeletal repair","volume":"1117","author":"Nixon","year":"2007","journal-title":"Ann N Y Acad Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/humc.2017.142","article-title":"Gene therapy for osteoarthritis: pharmacokinetics of intra-articular self-complementary adeno-associated virus interleukin-1 receptor antagonist delivery in an equine model","volume":"29","author":"Watson Levings","year":"2018","journal-title":"Hum Gene Ther Clin Dev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/hum.1994.5.1-19","article-title":"Improved methods of retroviral vector transduction and production for gene therapy","volume":"5","author":"Kotani","year":"1994","journal-title":"Hum Gene Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1126\/science.8493530","article-title":"The basic science of gene therapy","volume":"260","author":"Mulligan","year":"1993","journal-title":"Science."},{"key":"B59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/35038533","article-title":"Gene therapy: trials and tribulations","volume":"1","author":"Somia","year":"2000","journal-title":"Nat Rev Genet."},{"key":"B60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11926-004-0081-5","article-title":"Gene therapies for osteoarthritis","volume":"6","author":"Evans","year":"2004","journal-title":"Curr Rheumatol Rep."},{"key":"B61","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1006\/mthe.2002.0711","article-title":"Ex vivo gene delivery of Il-1ra and soluble Tnf receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis","volume":"6","author":"Kim","year":"2002","journal-title":"Mol Ther."},{"key":"B62","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1073\/pnas.93.1.402","article-title":"Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist Cdna","volume":"93","author":"Makarov","year":"1996","journal-title":"Proc Natl Acad Sci USA."},{"key":"B63","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/jgm.2774","article-title":"Ex vivo gene delivery to synovium using foamy viral vectors","volume":"16","author":"Armbruster","year":"2014","journal-title":"J Gene Med."},{"key":"B64","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/1529-0131(200108)44:8<1943::AID-ART332>3.0.CO;2-Z","article-title":"Fibroblast-mediated delivery of growth factor complementary DNA into mouse joints induces chondrogenesis but avoids the disadvantages of direct viral gene transfer","volume":"44","author":"Gelse","year":"2001","journal-title":"Arthritis Rheum."},{"key":"B65","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/jor.1100150616","article-title":"Myoblast-Mediated gene transfer to the joint","volume":"15","author":"Day","year":"1997","journal-title":"J Orthop Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"10764","DOI":"10.1073\/pnas.90.22.10764","article-title":"Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer","volume":"90","author":"Bandara","year":"1993","journal-title":"Proc Natl Acad Sci USA."},{"key":"B67","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1302\/0301-620X.89B5.18343","article-title":"Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model","volume":"89","author":"Goodrich","year":"2007","journal-title":"J Bone Joint Surg Br."},{"key":"B68","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/art.20739","article-title":"Repair of articular cartilage defect by autologous transplantation of basic fibroblast growth factor gene-transduced chondrocytes with adeno-associated virus vector","volume":"52","author":"Yokoo","year":"2005","journal-title":"Arthritis Rheum."},{"key":"B69","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1302\/0301-620x.84b2.11167","article-title":"Insulin-like growth factor-I enhances cell-based repair of articular cartilage","volume":"84","author":"Fortier","year":"2002","journal-title":"J Bone Joint Surg Br"},{"key":"B70","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0736-0266(02)00264-4","article-title":"Acceleration of cartilage repair by genetically modified chondrocytes over expressing bone morphogenetic protein-7","volume":"21","author":"Hidaka","year":"2003","journal-title":"J Orthop Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/mt.2014.198","article-title":"Implantation of Raav5-Igf-I transduced autologous chondrocytes improves cartilage repair in full-thickness defects in the equine model","volume":"23","author":"Ortved","year":"2015","journal-title":"Mol Ther."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.joca.2015.12.018","article-title":"Not single but periodic injections of synovial mesenchymal stem cells maintain viable cells in knees and inhibit osteoarthritis progression in rats","volume":"24","author":"Ozeki","year":"2016","journal-title":"Osteoarthritis Cartilage."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.joca.2012.06.002","article-title":"Intra-Articular injection of human mesenchymal stem cells (Mscs) promote rat meniscal regeneration by being activated to express indian hedgehog that enhances expression of type II collagen","volume":"20","author":"Horie","year":"2012","journal-title":"Osteoarthritis Cartilage."},{"key":"B74","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/art.1780390515","article-title":"Direct gene delivery to synovium: an evaluation of potential vectors in vitro and in vivo","volume":"39","author":"Nita","year":"1996","journal-title":"Arthritis Rheum."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1172\/JCI116614","article-title":"Adenoviral-mediated gene transfer to rabbit synovium in vivo","volume":"92","author":"Roessler","year":"1993","journal-title":"J Clin Invest."},{"key":"B76","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1073\/pnas.95.8.4613","article-title":"Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor \u03b1 soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects","volume":"95","author":"Ghivizzani","year":"1998","journal-title":"Proc Natl Acad Sci USA."},{"key":"B77","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1006\/mthe.2002.0562","article-title":"In vivo gene delivery to synovium by lentiviral vectors","volume":"5","author":"Gouze","year":"2002","journal-title":"Mol Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1136\/ard.2004.035063","article-title":"Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy","volume":"64","author":"Adriaansen","year":"2005","journal-title":"Ann Rheum Dis."},{"key":"B79","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/104303401750061186","article-title":"Direct adenovirus-mediated insulin-like growth factor I gene transfer enhances transplant chondrocyte function","volume":"12","author":"Brower-Toland","year":"2001","journal-title":"Hum Gene Ther."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/sj.gt.3302757","article-title":"Direct adenovirus-mediated Igf-I gene transduction of synovium induces persisting synovial fluid Igf-I ligand elevations","volume":"13","author":"Goodrich","year":"2006","journal-title":"Gene Ther."},{"key":"B81","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/gt.2015.21","article-title":"Scaavil-1ra dosing trial in a large animal model and validation of long-term expression with repeat administration for osteoarthritis therapy","volume":"22","author":"Goodrich","year":"2015","journal-title":"Gene Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1038\/mtna.2012.61","article-title":"Optimization of scaavil-1ra in vitro and in vivo to deliver high levels of therapeutic protein for treatment of osteoarthritis","volume":"2","author":"Goodrich","year":"2013","journal-title":"Mol Ther Nucleic Acids."},{"key":"B83","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.joca.2015.12.001","article-title":"Adeno-Associated virus gene therapy vector scaavigf-I for transduction of equine articular chondrocytes and Rna-Seq analysis","volume":"24","author":"Hemphill","year":"2016","journal-title":"Osteoarthritis Cartilage."},{"key":"B84","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"Lmo2-Associated clonal t cell proliferation in two patients after gene therapy for scid-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science."},{"key":"B85","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer","volume":"80","author":"Raper","year":"2003","journal-title":"Mol Genet Metab."},{"key":"B86","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (Scid)-X1 disease","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science."},{"key":"B87","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJM200301163480314","article-title":"A serious adverse event after successful gene therapy for x-linked severe combined immunodeficiency","volume":"348","author":"Hacein-Bey-Abina","year":"2003","journal-title":"N Engl J Med."},{"key":"B88","doi-asserted-by":"publisher","first-page":"e3021","DOI":"10.1002\/jgm.3021","article-title":"Cytokine-Induced interleukin-1 receptor antagonist protein expression in genetically engineered equine mesenchymal stem cells for osteoarthritis treatment","volume":"20","author":"Gabner","year":"2018","journal-title":"J Gene Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S1525-0016(03)00024-8","article-title":"Lentiviral-Mediated gene delivery to synovium: potent intra-articular expression with amplification by inflammation","volume":"7","author":"Gouze","year":"2003","journal-title":"Mol Ther."},{"key":"B90","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1089\/hum.2020.319","article-title":"Adeno-Associated virus-mediated overexpression of interleukin-10 affects the immunomodulatory properties of equine bone marrow-derived mesenchymal stem cells","volume":"32","author":"Cameron","year":"2021","journal-title":"Hum Gene Ther."},{"key":"B91","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/humc.2017.143","article-title":"Self-Complementary adeno-associated virus-mediated interleukin-1 receptor antagonist gene delivery for the treatment of osteoarthritis: test of efficacy in an equine model","volume":"29","author":"Watson Levings","year":"2018","journal-title":"Hum Gene Ther Clin Dev."},{"key":"B92","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0749-0739(17)30059-7","article-title":"Gene therapy: future therapies in osteoarthritis","volume":"17","author":"Frisbie","year":"2001","journal-title":"Vet Clin N Am Equine Prac."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/sj.gt.3301014","article-title":"Intra-Articular delivery of a herpes simplex virus Il-1ra gene vector reduces inflammation in a rabbit model of arthritis","volume":"6","author":"Oligino","year":"1999","journal-title":"Gene Ther."},{"key":"B94","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0169-409X(97)00021-5","article-title":"Progress in development of herpes simplex virus gene vectors for treatment of rheumatoid arthritis","volume":"27","author":"Glorioso","year":"1997","journal-title":"Adv Drug Deliv Rev."},{"key":"B95","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.rvsc.2014.09.004","article-title":"Efficient transduction of equine adipose-derived mesenchymal stem cells by Vsv-G pseudotyped lentiviral vectors","volume":"97","author":"Petersen","year":"2014","journal-title":"Res Vet Sci."},{"key":"B96","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/gt.2011.173","article-title":"Suppression of collagen-induced arthritis by intra-articular lentiviral vector-mediated delivery of toll-like receptor 7 short hairpin Rna gene","volume":"19","author":"Chen","year":"2012","journal-title":"Gene Ther."},{"key":"B97","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jphs.2017.02.001","article-title":"Intra-Articular lentivirus-mediated gene therapy targeting cracm1 for the treatment of collagen-induced arthritis","volume":"133","author":"Liu","year":"2017","journal-title":"J Pharmacol Sci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.2741\/1607","article-title":"Adenovirus vectors deleted for genes essential for viral DNA replication","volume":"10","author":"Schaack","year":"2005","journal-title":"Front Biosci."},{"key":"B99","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1128\/JVI.72.2.926-933.1998","article-title":"Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted","volume":"72","author":"Amalfitano","year":"1998","journal-title":"J Virol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2174\/157488608783333925","article-title":"Improving safety of gene therapy","volume":"3","author":"R\u00e4ty","year":"2008","journal-title":"Curr Drug Saf."},{"key":"B101","doi-asserted-by":"publisher","first-page":"e139538","DOI":"10.1172\/jci.insight.139538","article-title":"Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements","volume":"5","author":"Wang","year":"2020","journal-title":"JCI Insight."},{"key":"B102","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ymgme.2018.04.001","article-title":"Conditional disruption of hepatic carbamoyl phosphate synthetase 1 in mice results in hyperammonemia without orotic aciduria and can be corrected by liver-directed gene therapy","volume":"124","author":"Khoja","year":"2018","journal-title":"Mol Genet Metab."},{"key":"B103","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/B978-0-12-800276-6.00017-6","article-title":"17\u2014helper-dependent adenoviral vectors","volume-title":"Adenoviral Vectors for Gene Therapy.","author":"Brunetti-Pierri","year":"2016"},{"key":"B104","doi-asserted-by":"publisher","first-page":"R7","DOI":"10.1093\/hmg\/ddr143","article-title":"Helper-Dependent adenoviral vectors for liver-directed gene therapy","volume":"20","author":"Brunetti-Pierri","year":"2011","journal-title":"Hum Mol Genet."},{"key":"B105","doi-asserted-by":"publisher","first-page":"001","DOI":"10.4172\/2157-7412.S5-001","article-title":"Helper-Dependent adenoviral vectors","author":"Rosewell","year":"2011","journal-title":"J Genet Syndr Gene Ther."},{"key":"B106","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s11262-017-1471-x","article-title":"Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models","volume":"53","author":"Brunetti-Pierri","year":"2017","journal-title":"Virus Genes."},{"key":"B107","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1089\/hum.2005.16.811","article-title":"Sustained phenotypic correction of canine hemophilia b after systemic administration of helper-dependent adenoviral vector","volume":"16","author":"Brunetti-Pierri","year":"2005","journal-title":"Hum Gene Ther."},{"key":"B108","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1182\/blood-2003-05-1426","article-title":"Helper-Dependent adenoviral vectors mediate therapeutic factor viii expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A","volume":"103","author":"Brown","year":"2004","journal-title":"Blood."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/j.1538-7836.2006.01901.x","article-title":"Helper-Dependent adenoviral gene therapy mediates long-term correction of the clotting defect in the canine hemophilia a model","volume":"4","author":"Mc","year":"2006","journal-title":"J Thromb Haemost."},{"key":"B110","doi-asserted-by":"publisher","first-page":"12816","DOI":"10.1073\/pnas.96.22.12816","article-title":"Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons","volume":"96","author":"Morral","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"key":"B111","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1089\/hum.2006.17.391","article-title":"Improved hepatic transduction, reduced systemic vector dissemination, and long-term transgene expression by delivering helper-dependent adenoviral vectors into the surgically isolated liver of nonhuman primates","volume":"17","author":"Brunetti-Pierri","year":"2006","journal-title":"Hum Gene Ther."},{"key":"B112","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/gt.2015.64","article-title":"Helper-Dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression","volume":"22","author":"Unzu","year":"2015","journal-title":"Gene Therapy."},{"key":"B113","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1089\/hum.2013.071","article-title":"Transgene expression up to 7 years in nonhuman primates following hepatic transduction with helper-dependent adenoviral vectors","volume":"24","author":"Brunetti-Pierri","year":"2013","journal-title":"Hum Gene Ther."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/art.40668","article-title":"Disease-Modifying osteoarthritis treatment with interleukin-1 receptor antagonist gene therapy in small and large animal models","volume":"70","author":"Nixon","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"16008","DOI":"10.1038\/mtm.2016.8","article-title":"Treatment of osteoarthritis using a helper-dependent adenoviral vector retargeted to chondrocytes","volume":"3","author":"Ruan","year":"2016","journal-title":"Mol Ther Methods Clin Dev."},{"key":"B116","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1089\/hum.2018.106","article-title":"Combinatorial Prg4 and Il-1ra gene therapy protects against hyperalgesia and cartilage degeneration in post-traumatic osteoarthritis","volume":"30","author":"Stone","year":"2019","journal-title":"Hum Gene Ther."},{"key":"B117","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/10430340460732445","article-title":"Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates","volume":"15","author":"Brunetti-Pierri","year":"2004","journal-title":"Hum Gene Ther."},{"key":"B118","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1146\/annurev-virology-031413-085355","article-title":"Aav-mediated gene therapy for research and therapeutic purposes","volume":"1","author":"Samulski","year":"2014","journal-title":"Annu Rev Virol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/v12060662","article-title":"The interplay between adeno-associated virus and its helper viruses","volume":"12","author":"Meier","year":"2020","journal-title":"Viruses."},{"key":"B120","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1128\/jvi.70.3.1845-1854.1996","article-title":"Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers","volume":"70","author":"Weitzman","year":"1996","journal-title":"J Virol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1590\/S0100-879X2011007500123","article-title":"Adeno-Associated virus for cystic fibrosis gene therapy","volume":"44","author":"Martini","year":"2011","journal-title":"Braz J Med Biol Res."},{"key":"B122","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1182\/blood-2008-01-131417","article-title":"Intraarticular factor Ix protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor Ix","volume":"112","author":"Sun","year":"2008","journal-title":"Blood."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1089\/hum.2009.030","article-title":"Ex vivo serotype-specific transduction of equine joint tissue by self-complementary adeno-associated viral vectors","volume":"20","author":"Goodrich","year":"2009","journal-title":"Hum Gene Ther."},{"key":"B124","doi-asserted-by":"publisher","first-page":"6324","DOI":"10.1016\/j.biomaterials.2011.05.017","article-title":"Targeted delivery of non-viral vectors to cartilage in vivo using a chondrocyte-homing peptide identified by phage display","volume":"32","author":"Pi","year":"2011","journal-title":"Biomaterials."},{"key":"B125","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1089\/hum.2017.181","article-title":"Gene delivery to joints by intra-articular injection","volume":"29","author":"Evans","year":"2018","journal-title":"Hum Gene Ther."},{"key":"B126","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1089\/104303403321208998","article-title":"Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage","volume":"14","author":"Madry","year":"2003","journal-title":"Hum Gene Ther."},{"key":"B127","doi-asserted-by":"publisher","first-page":"5861","DOI":"10.1038\/srep05861","article-title":"Adeno-Associated viral vectors show serotype specific transduction of equine joint tissue explants and cultured monolayers","volume":"4","author":"Hemphill","year":"2014","journal-title":"Sci Rep."},{"key":"B128","doi-asserted-by":"publisher","first-page":"10613","DOI":"10.1073\/pnas.90.22.10613","article-title":"Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector","volume":"90","author":"Flotte","year":"1993","journal-title":"Proc Natl Acad Sci USA."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1080\/14712598.2017.1347630","article-title":"Adeno-Associated virus (Aav) gene therapy for cystic fibrosis: current barriers and recent developments","volume":"17","author":"Guggino","year":"2017","journal-title":"Expert Opin Biol Ther."},{"key":"B130","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/bies.950170310","article-title":"The cryptic life style of adenoassociated virus","volume":"17","author":"Berns","year":"1995","journal-title":"Bioessays."},{"key":"B131","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/microbiolspec.MDNA3-0052-2014","article-title":"Adeno-associated virus as a mammalian DNA vector","volume":"3","author":"Salganik","year":"2015","journal-title":"Microbiol Spectr"},{"key":"B132","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/B978-0-12-386509-0.00012-0","article-title":"Adeno-Associated virus vectorology, manufacturing, and clinical applications","volume":"507","author":"Grieger","year":"2012","journal-title":"Methods Enzymol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1038\/sj.gt.3302134","article-title":"Adeno-Associated virus terminal repeat (Tr) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo","volume":"10","author":"McCarty","year":"2003","journal-title":"Gene Ther."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","article-title":"Self-Complementary recombinant adeno-associated virus (scaav) vectors promote efficient transduction independently of DNA synthesis","volume":"8","author":"McCarty","year":"2001","journal-title":"Gene Ther."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/mt.2008.171","article-title":"Self-Complementary aav vectors; advances and applications","volume":"16","author":"McCarty","year":"2008","journal-title":"Mol Ther."},{"key":"B136","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/jgm.1334","article-title":"Intra-Articular gene delivery and expression of interleukin-1ra mediated by self-complementary adeno-associated virus","volume":"11","author":"Kay","year":"2009","journal-title":"J Gene Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/sj.gt.3303074","article-title":"Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2\/8","volume":"15","author":"Natkunarajah","year":"2008","journal-title":"Gene Ther."},{"key":"B138","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1136\/annrheumdis-2018-214724","article-title":"Exploration of Crispr\/Cas9-based gene editing as therapy for osteoarthritis","volume":"78","author":"Zhao","year":"2019","journal-title":"Ann Rheum Dis."},{"key":"B139","doi-asserted-by":"publisher","first-page":"Ge01","DOI":"10.7860\/JCDR\/2015\/10443.5394","article-title":"Non viral vectors in gene therapy- an overview","volume":"9","author":"Ramamoorth","year":"2015","journal-title":"J Clin Diagn Res."},{"key":"B140","doi-asserted-by":"publisher","first-page":"618399","DOI":"10.3389\/fbioe.2020.618399","article-title":"Non-Viral gene therapy for osteoarthritis","volume":"8","author":"Uzieliene","year":"2021","journal-title":"Front Bioeng Biotechnol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1517\/14712598.8.10.1507","article-title":"Plasmid DNA as a safe gene delivery vehicle for treatment of chronic inflammatory disease","volume":"8","author":"Clanchy","year":"2008","journal-title":"Exp Opin Biol Ther."},{"key":"B142","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/genes8020065","article-title":"Advances in non-viral DNA vectors for gene therapy","volume":"8","author":"Hardee","year":"2017","journal-title":"Genes."},{"key":"B143","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-Viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat Rev Genet."},{"key":"B144","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bbi.2020.08.005","article-title":"Targeted interleukin-10 plasmid DNA therapy in the treatment of osteoarthritis: toxicology and pain efficacy assessments","volume":"90","author":"Watkins","year":"2020","journal-title":"Brain Behav Immun."},{"key":"B145","doi-asserted-by":"publisher","first-page":"e3015","DOI":"10.1002\/jgm.3015","article-title":"Gene therapy clinical trials worldwide to 2017: an update","volume":"20","author":"Ginn","year":"2018","journal-title":"J Gene Med."},{"key":"B146","doi-asserted-by":"publisher","first-page":"R42","DOI":"10.1093\/hmg\/ddv451","article-title":"Progress and challenges in viral vector manufacturing","volume":"25","author":"van der Loo","year":"2015","journal-title":"Hum Mol Genet."},{"key":"B147","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrrheum.2015.28","article-title":"Gene therapy approaches to regenerating the musculoskeletal system","volume":"11","author":"Evans","year":"2015","journal-title":"Nat Rev Rheumatol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4155\/pbp.14.16","article-title":"Manufacturing of viral vectors for gene therapy: part I. Upstream processing","volume":"2","author":"Merten","year":"2014","journal-title":"Pharm Bioprocess."},{"key":"B149","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1002\/jgm.499","article-title":"State-of-the-Art of the production of retroviral vectors","volume":"6","author":"Merten","year":"2004","journal-title":"J Gene Med."},{"key":"B150","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/biot.201500176","article-title":"Rational plasmid design and bioprocess optimization to enhance recombinant adeno-associated virus (aav) productivity in mammalian Cells","volume":"11","author":"Emmerling","year":"2016","journal-title":"Biotechnol J."},{"key":"B151","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1472-6750-9-10","article-title":"Simplified production and concentration of Hiv-1-based lentiviral vectors using hyperflask vessels and anion exchange membrane chromatography","volume":"9","author":"Kutner","year":"2009","journal-title":"BMC Biotechnol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1089\/hum.2015.081","article-title":"Process development of adenoviral vector production in fixed bed bioreactor: from bench to commercial scale","volume":"26","author":"Lesch","year":"2015","journal-title":"Hum Gene Ther."},{"key":"B153","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1021\/bp000162z","article-title":"Comparison of different bioreactor systems for the production of high titer retroviral vectors","volume":"17","author":"Merten","year":"2001","journal-title":"Biotechnol Prog."},{"key":"B154","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/CJI.0000000000000072","article-title":"Large-Scale clinical-grade retroviral vector production in a fixed-bed bioreactor","volume":"38","author":"Wang","year":"2015","journal-title":"J Immunother."},{"key":"B155","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.1016\/j.jip.2011.05.008","article-title":"Latest developments in the large-scale production of adeno-associated virus vectors in insect cells toward the treatment of neuromuscular diseases","volume":"107","author":"Galibert","year":"2011","journal-title":"J Invertebr Pathol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/sj.gt.3300857","article-title":"Enhancement of calcium phosphate-mediated transfection by inclusion of adenovirus in coprecipitates","volume":"6","author":"Lee","year":"1999","journal-title":"Gene Ther."},{"key":"B157","doi-asserted-by":"publisher","first-page":"8392","DOI":"10.1073\/pnas.90.18.8392","article-title":"Production of high-titer helper-free retroviruses by transient transfection","volume":"90","author":"Pear","year":"1993","journal-title":"Proc Natl Acad Sci USA."},{"key":"B158","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1517\/14712598.2013.779249","article-title":"New developments in lentiviral vector design, production and purification","volume":"13","author":"Segura","year":"2013","journal-title":"Exp Opin Biol Ther."},{"key":"B159","doi-asserted-by":"publisher","first-page":"10405","DOI":"10.1073\/pnas.162250899","article-title":"The atomic structure of adeno-associated virus (Aav-2), a vector for human gene therapy","volume":"99","author":"Xie","year":"2002","journal-title":"Proc Natl Acad Sci USA."},{"key":"B160","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41434-019-0074-7","article-title":"Delivering cellular and gene therapies to patients: solutions for realizing the potential of the next generation of medicine","volume":"27","author":"Elverum","year":"2020","journal-title":"Gene Ther."},{"key":"B161","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.beha.2018.01.002","article-title":"Gmp car-T cell production","volume":"31","author":"Gee","year":"2018","journal-title":"Best Pract Res Clin Haematol."},{"key":"B162","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.copbio.2020.05.005","article-title":"Challenges and advantages of cell therapy manufacturing under good manufacturing practices within the hospital setting","volume":"65","author":"Iancu","year":"2020","journal-title":"Curr Opin Biotechnol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s10529-019-02732-z","article-title":"Automation in cell and gene therapy manufacturing: from past to future","volume":"41","author":"Moutsatsou","year":"2019","journal-title":"Biotechnol Lett."},{"key":"B164","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2217\/rme.14.73","article-title":"The translation of cell-based therapies: clinical landscape and manufacturing challenges","volume":"10","author":"Heathman","year":"2015","journal-title":"Regen Med."},{"key":"B165","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/term.217","article-title":"Human cell culture process capability: a comparison of manual and automated production","volume":"4","author":"Liu","year":"2010","journal-title":"J Tissue Eng Regen Med."},{"key":"B166","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10616-007-9091-2","article-title":"Manufacture of a human mesenchymal stem cell population using an automated cell culture platform","volume":"55","author":"Thomas","year":"2007","journal-title":"Cytotechnology."},{"key":"B167","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1098\/rsta.2011.0049","article-title":"Precision manufacturing for clinical-quality regenerative medicines","volume":"370","author":"Williams","year":"2012","journal-title":"Philos Trans R Soc A Math Phys Eng Sci."},{"key":"B168","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2217\/rme.09.64","article-title":"Assessing the value of autologous and allogeneic cells for regenerative medicine","volume":"4","author":"Mason","year":"2009","journal-title":"Regener Med."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.joca.2008.03.008","article-title":"Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses","volume":"16","author":"Frisbie","year":"2008","journal-title":"Osteoarthritis Cartilage."},{"key":"B170","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00402-007-0407-7","article-title":"Igf-1 gene therapy to protect articular cartilage in a rat model of joint damage","volume":"128","author":"Izal","year":"2008","journal-title":"Arch Orthop Trauma Surg."},{"key":"B171","doi-asserted-by":"publisher","first-page":"735472","DOI":"10.1155\/2012\/735472","article-title":"Inflammation and immune response of intra-articular serotype 2 adeno-associated virus or adenovirus vectors in a large animal model","volume":"2012","author":"Ishihara","year":"2012","journal-title":"Arthritis."},{"key":"B172","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/gt.2012.81","article-title":"Scaav-Mediated gene transfer of interleukin-1-receptor antagonist to synovium and articular cartilage in large mammalian joints","volume":"20","author":"Watson","year":"2013","journal-title":"Gene Ther."},{"key":"B173","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1093\/nar\/26.2.486","article-title":"Activation of stress-activated map protein kinases up-regulates expression of transgenes driven by the cytomegalovirus immediate\/early promoter","volume":"26","author":"Bruening","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"B174","doi-asserted-by":"publisher","first-page":"10445","DOI":"10.1158\/0008-5472.CAN-07-1955","article-title":"Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy","volume":"67","author":"Svensson","year":"2007","journal-title":"Cancer Res."},{"key":"B175","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s10753-006-9005-z","article-title":"Analysis of signal transduction pathways in macrophages using expression vectors with cmv promoters: a cautionary tale","volume":"29","author":"Ramanathan","year":"2005","journal-title":"Inflammation."},{"key":"B176","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0083-6729(06)74016-X","article-title":"The role of Il-1 and Il-1ra in joint inflammation and cartilage degradation","volume":"74","author":"Jacques","year":"2006","journal-title":"Vitam Horm."},{"key":"B177","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.4049\/jimmunol.163.9.5049","article-title":"Il-1\u03b1\u03b2 blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas Tnf-\u03b1 blockade only ameliorates joint inflammation","volume":"163","author":"Joosten","year":"1999","journal-title":"J Immunol."},{"key":"B178","first-page":"64","article-title":"Suppression of Intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium","volume":"1","author":"Hung","year":"1994","journal-title":"Gene Ther."},{"key":"B179","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/1529-0131(200002)43:2<289::AID-ANR8>3.0.CO;2-H","article-title":"Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist","volume":"43","author":"Pan","year":"2000","journal-title":"Arthritis Rheum."},{"key":"B180","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4049\/jimmunol.155.2.796","article-title":"Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes","volume":"155","author":"Geng","year":"1995","journal-title":"J Immunol."},{"key":"B181","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.4049\/jimmunol.147.11.3915","article-title":"Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide","volume":"147","author":"Stadler","year":"1991","journal-title":"J Immunol."},{"key":"B182","doi-asserted-by":"crossref","first-page":"712","DOI":"10.2460\/ajvr.1998.59.06.712","article-title":"Cloning of equine interleukin 1 receptor antagonist and determination of its full-length Cdna sequence","volume":"59","author":"Howard","year":"1998","journal-title":"Am J Vet Res."},{"key":"B183","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/art.24096","article-title":"Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study","volume":"61","author":"Chevalier","year":"2009","journal-title":"Arthritis Care Res."},{"key":"B184","first-page":"225","article-title":"Interleukin 1 receptor antagonist anakinra improves functional status in patients with rheumatoid arthritis","volume":"30","author":"Cohen","year":"2003","journal-title":"J Rheumatol."},{"key":"B185","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1742-1241.2003.tb10469.x","article-title":"Anakinra: the first interleukin-1 inhibitor in the treatment of rheumatoid arthritis","volume":"57","author":"Kary","year":"2003","journal-title":"Int J Clin Pract."},{"key":"B186","doi-asserted-by":"publisher","first-page":"ii29","DOI":"10.1093\/rheumatology\/keg330","article-title":"Addressing the safety of anakinra in patients with rheumatoid arthritis","volume":"42","author":"Fleischmann","year":"2003","journal-title":"Rheumatology."},{"key":"B187","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/sj.gt.3302396","article-title":"Gene-Mediated restoration of cartilage matrix by combination insulin-like growth factor-I\/interleukin-1 receptor antagonist therapy","volume":"12","author":"Nixon","year":"2005","journal-title":"Gene Ther."},{"key":"B188","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2460\/ajvr.2002.63.301","article-title":"Phenotypic expression of equine articular chondrocytes grown in three-dimensional cultures supplemented with supraphysiologic concentrations of insulin-like growth factor-I","volume":"63","author":"Fortier","year":"2002","journal-title":"J Am Vet Med Assoc."},{"key":"B189","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1042\/bj2600543","article-title":"Insulin-Like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines","volume":"260","author":"Tyler","year":"1989","journal-title":"Biochem J."},{"key":"B190","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1002\/1529-0131(200011)43:11<2563::AID-ANR25>3.0.CO;2-8","article-title":"Adenovirus-Mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints","volume":"43","author":"Mi","year":"2000","journal-title":"Arthritis Rheum."},{"key":"B191","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.BRS.0000058946.64222.92","article-title":"Potential use of Sox9 gene therapy for intervertebral degenerative disc disease","volume":"28","author":"Paul","year":"2003","journal-title":"Spine."},{"key":"B192","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3892\/ijmm.2013.1497","article-title":"Treatment of rabbit intervertebral disc degeneration with co-transfection by adeno-associated virus-mediated Sox9 and osteogenic protein-1 double genes in vivo","volume":"32","author":"Ren","year":"2013","journal-title":"Int J Mol Med."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3390\/jcm8101637","article-title":"Effects of raav-mediated Sox9 overexpression on the biological activities of human osteoarthritic articular chondrocytes in their intrinsic three-dimensional environment","volume":"8","author":"Daniels","year":"2019","journal-title":"J Clin Med."},{"key":"B194","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1002\/jor.23228","article-title":"Raav-Mediated combined gene transfer and overexpression of Tgf-\u03b2 and sox9 remodels human osteoarthritic articular cartilage","volume":"34","author":"Tao","year":"2016","journal-title":"J Orthop Res."},{"key":"B195","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/sj.gt.3301811","article-title":"Inhibition of cartilage destruction by double gene transfer of Il-1ra and Il-10 involves the activin pathway","volume":"9","author":"Neumann","year":"2002","journal-title":"Gene Therapy."},{"key":"B196","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/sj.gt.3301165","article-title":"Amelioration of Established collagen induced arthritis by systemic Il-10 gene delivery","volume":"7","author":"Fellowes","year":"2000","journal-title":"Gene Ther."},{"key":"B197","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1136\/annrheumdis-2014-205223","article-title":"Disease-Regulated local Il-10 gene therapy diminishes synovitis and cartilage proteoglycan depletion in experimental arthritis","volume":"74","author":"Vermeij","year":"2015","journal-title":"Ann Rheum Dis."},{"key":"B198","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.4049\/jimmunol.161.3.1516","article-title":"Inhibition of collagen-induced arthritis in mice by viral Il-10 gene transfer","volume":"161","author":"Ma","year":"1998","journal-title":"J Immunol."},{"key":"B199","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.4049\/jimmunol.160.11.5213","article-title":"Adenovirus-mediated transfer of viral Il-10 gene inhibits murine collagen-induced arthritis","volume":"160","author":"Apparailly","year":"1998","journal-title":"J Immunol."},{"key":"B200","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.4049\/jimmunol.162.6.3625","article-title":"Adenoviral transfer of the viral Il-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws","volume":"162","author":"Whalen","year":"1999","journal-title":"J Immunol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000087655","article-title":"Central proinflammatory cytokines and pain enhancement","volume":"14","author":"Wieseler-Frank","year":"2005","journal-title":"Neurosignals."},{"key":"B202","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neuropharm.2014.10.020","article-title":"The therapeutic potential of interleukin-10 in neuroimmune diseases","volume":"96","author":"Kwilasz","year":"2015","journal-title":"Neuropharmacology."},{"key":"B203","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.bbi.2006.10.012","article-title":"Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats","volume":"21","author":"Ledeboer","year":"2007","journal-title":"Brain Behav Immunity."},{"key":"B204","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2174\/1566523218666180510165123","article-title":"Aav-mediated overexpression of Il-10 mitigates the inflammatory cascade in stimulated equine chondrocyte pellets","volume":"18","author":"Ortved","year":"2018","journal-title":"Current Gene Therapy."},{"key":"B205","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1089\/hum.2019.195","article-title":"Sustained Interleukin-10 transgene expression following intra-articular Aav5-Il-10 administration to horses","volume":"31","author":"Moss","year":"2020","journal-title":"Hum Gene Ther."},{"key":"B206","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.joca.2016.07.021","article-title":"Lubricin\/Proteoglycan 4 increases in both experimental and naturally occurring equine osteoarthritis","volume":"25","author":"Reesink","year":"2017","journal-title":"Osteoarthritis Cartilage."},{"key":"B207","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.1073\/pnas.0608558104","article-title":"The role of lubricin in the mechanical behavior of synovial fluid","volume":"104","author":"Jay","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B208","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/art.24304","article-title":"Prevention of cartilage degeneration in a rat model of osteoarthritis by intraarticular treatment with recombinant lubricin","volume":"60","author":"Flannery","year":"2009","journal-title":"Arthritis Rheum."},{"key":"B209","doi-asserted-by":"publisher","first-page":"e0210601","DOI":"10.1371\/journal.pone.0210601","article-title":"Prg4 prevents osteoarthritis induced by dominant-negative interference of Tgf-\u00df signaling in mice","volume":"14","author":"Chavez","year":"2019","journal-title":"PLoS ONE."},{"key":"B210","doi-asserted-by":"publisher","first-page":"176ra34","DOI":"10.1126\/scitranslmed.3005409","article-title":"Proteoglycan 4 expression protects against the development of osteoarthritis","volume":"5","author":"Ruan","year":"2013","journal-title":"Sci Transl Med."},{"key":"B211","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2106\/00004623-200002000-00001","article-title":"Repair of articular cartilage defects one year after treatment with recombinant human bone morphogenetic protein-2 (Rhbmp-2)","volume":"82","author":"Sellers","year":"2000","journal-title":"J Bone Joint Surg Am."},{"key":"B212","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/(SICI)1097-4636(20000315)49:4<506::AID-JBM9>3.0.CO;2-A","article-title":"Use of recombinant human osteogenic protein-1 for the repair of subchondral defects in articular cartilage in goats","volume":"49","author":"Louwerse","year":"2000","journal-title":"J Biomed Mater Res."},{"key":"B213","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0736-0266(01)00019-5","article-title":"Enhanced matrix synthesis and in vitro formation of cartilage-like tissue by genetically modified chondrocytes expressing Bmp-7","volume":"19","author":"Hidaka","year":"2001","journal-title":"J Orthop Res."}],"updated-by":[{"DOI":"10.3389\/fvets.2022.1117776","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000}}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.962898\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T23:00:20Z","timestamp":1728082820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.962898\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":213,"alternative-id":["10.3389\/fvets.2022.962898"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2022.962898","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fvets.2022.1117776","asserted-by":"object"}]},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]},"article-number":"962898"}}